Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MBGPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 71.75M
December 31, 2025 74.01M
September 30, 2025 73.75M
June 30, 2025 74.43M
March 31, 2025 69.97M
December 31, 2024 63.90M
September 30, 2024 93.26M
June 30, 2024 90.61M
March 31, 2024 59.11M
December 31, 2023 62.98M
September 30, 2023 59.29M
June 30, 2023 50.89M
March 31, 2023 53.16M
December 31, 2022 54.17M
September 30, 2022 49.54M
June 30, 2022 54.23M
March 31, 2022 48.48M
December 31, 2021 49.80M
September 30, 2021 51.84M
June 30, 2021 53.38M
March 31, 2021 53.14M
December 31, 2020 58.52M
September 30, 2020 40.68M
June 30, 2020 39.09M
March 31, 2020 37.27M
Date Value
June 30, 2019 130.41M
March 31, 2019 201.06M
December 31, 2018 141.17M
September 30, 2018
June 30, 2018 141.48M
March 31, 2018 145.59M
December 31, 2017 149.41M
September 30, 2017 146.36M
June 30, 2017 143.69M
March 31, 2017 137.39M
December 31, 2016 135.63M
September 30, 2016 97.57M
June 30, 2016 85.70M
March 31, 2016 84.71M
December 31, 2015 47.14M
September 30, 2015 48.27M
June 30, 2015 50.24M
March 31, 2015 46.98M
December 31, 2014 45.95M
September 30, 2014 48.44M
June 30, 2014 53.64M
March 31, 2014 43.34M
December 31, 2013 42.29M
September 30, 2013 42.94M
June 30, 2013 39.28M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Orexo AB 64.08M
Swedencare AB 1.023B
Camurus AB 520.47M
Infant Bacterial Therapeutics AB 15.02M
AstraZeneca PLC 114.02B

Total Assets (Quarterly) Related Metrics